Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Search
Sign in
Sign up
JP Morgan Chase’s
ARS Pharmaceuticals
SPRY
Stock Holding History
JP Morgan Chase’s Portfolio
SPRY Stock Details
SPRY Fund Activity
Bought
Maintained
Sold
Shares
Call Options
Put Options
Quarter
Market Value
Status
Shares
Change in
Stake
Trade Value
Portfolio Weight
Portfolio Position
2026
Q1
$2.99M
Sell
382,801
-34,289
-8%
-$329K
﹤0.01%
3778
2025
Q4
$4.86M
Buy
417,090
+382,031
+1,090%
+$3.72M
﹤0.01%
3335
2025
Q3
$352K
Buy
35,059
+499
+1%
+$7.16K
﹤0.01%
5221
2025
Q2
$603K
Buy
34,560
+2,357
+7%
+$34K
﹤0.01%
4679
2025
Q1
$405K
Buy
32,203
+1,091
+4%
+$13.1K
﹤0.01%
4900
2024
Q4
$328K
Sell
31,112
-1,710
-5%
-$23.9K
﹤0.01%
5254
2024
Q3
$476K
Sell
32,822
-178
-0.5%
-$2.12K
﹤0.01%
4924
2024
Q2
$281K
Sell
33,000
-17,183
-34%
-$152K
﹤0.01%
4971
2024
Q1
$513K
Buy
50,183
+15,534
+45%
+$116K
﹤0.01%
4781
2023
Q4
$190K
Buy
34,649
+369
+1%
+$1.62K
﹤0.01%
5413
2023
Q3
$130K
Buy
34,280
+11,746
+52%
+$77.1K
﹤0.01%
5328
2023
Q2
$151K
Buy
22,534
+19,612
+671%
+$131K
﹤0.01%
5251
2023
Q1
$19K
Buy
2,922
+350
+14%
+$2.69K
﹤0.01%
5986
2022
Q4
$22K
Buy
2,572
+461
+22%
+$2.99K
﹤0.01%
5860
2022
Q3
$11K
Buy
2,111
+614
+41%
+$3.03K
﹤0.01%
5946
2022
Q2
$6K
Sell
1,497
-12,261
-89%
-$42.8K
﹤0.01%
6131
2022
Q1
$49K
Sell
13,758
-158,066
-92%
-$688K
﹤0.01%
5806
2021
Q4
$1.14M
Buy
171,824
+122,174
+246%
+$993K
﹤0.01%
4278
2021
Q3
$495K
Buy
49,650
+40,555
+446%
+$1M
﹤0.01%
4733
2021
Q2
$281K
Sell
9,095
-19,255
-68%
-$617K
﹤0.01%
5058
2021
Q1
$1.24M
Buy
+28,350
New
+$1.34M
﹤0.01%
4074
Other funds holding SPRY
RCM
RA Capital Management
Boston, Massachusetts
$9.44B AUM
157.3%
1-Year Est. Return
O
OrbiMed
New York
$5.05B AUM
125.28%
1-Year Est. Return
RCMNY
Rubric Capital Management (New York)
New York
$9.44B AUM
68.42%
1-Year Est. Return
DM
Deerfield Management
New York
$8.48B AUM
99.04%
1-Year Est. Return
Millennium Management
New York
$240B AUM
35.51%
1-Year Est. Return
BlackRock
New York
$5.72T AUM
30.48%
1-Year Est. Return
Aberdeen Group
Edinburgh, United Kingdom
$61.9B AUM
29.81%
1-Year Est. Return
SOCM
SR One Capital Management
Wayne, Pennsylvania
$915M AUM
209.71%
1-Year Est. Return
State Street
Boston, Massachusetts
$2.9T AUM
29.55%
1-Year Est. Return
Franklin Resources
San Mateo, California
$408B AUM
30.18%
1-Year Est. Return
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Theme
Close